![Global Viral Clearance Market](https://res.cloudinary.com/devmoveo/image/upload/v1706536382/skyquest/report/phpQbKExX.jpg)
Report ID: SQMIG35I2288
Report ID:
SQMIG35I2288 |
Region:
Global |
Published Date: February, 2024
Pages:
260
|
Tables:
120 |
Figures:
77
Viral Clearance Market size was valued at USD 492.9 billion in 2019 and is poised to grow from USD 535.6 billion in 2023 to USD 1519.7 billion by 2031, growing at a CAGR of 16.1% in the forecast period (2024-2031).
Viral clearance is the process of removal of viral particles and TSE (Transmissible spongiform encephalopathy) agents from the manufacturing process of development for monoclonal antibodies, recombinant proteins and glycoproteins, tissue, blood-derived products, and medical devices as these products are at risk from bacteria, chemical impurities, fungi, and from viruses. Viral contamination can affect cell culture processes, raw materials, bioreactor contamination, and downstream processing which in turn creates demand for viral safety practices. Increasing investments in the field of pharmaceutical and biotechnology and the rising demand for vaccines and other biotherapeutic agents are driving the market in the upcoming years.
US Viral Clearance Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2288